Open Letter to the Philadelphia Inquirer Over HPV School Mandate Plea

We found your Op-Ed by Eddy Bresnitz, It’s time for states to mandate the HPV vaccine for schoolchildren extremely troubling (See below). There are serious problems that our organization, Children’s Health Defense, finds impossible to accept with the distribution of this information. First, the idea of mandating a medical intervention implies that in medicine, a one-size-fits-all approach is in the person’s best interest. People’s individual physiologies and environmental exposures mean drugs and vaccines need to be administered safely by a physician who knows the medical history and health of the individual patient they are treating. This couldn’t be a more valid caution than for the HPV vaccine.

Dr. Bresnitz stealthily skirts over the potential of known and serious adverse events from the HPV vaccine by only stating that there are “no new serious adverse events” in the updated version of the vaccine. Don’t you believe your readership deserves to know about what is already known about the HPV vaccine’s adverse events? According to Merck’s package insert, at least 2% of recipients develop “systemic autoimmune disorders”. These could be lifelong.

But that’s the tip of the iceberg. Merck also discloses that recipients may also experience “respiratory, thoracic, and mediastinal disorders: Pulmonary embolism. Gastrointestinal disorders: pancreatitis general disorders and administration site conditions: Asthenia, chills, death, malaise hypersensitivity reactions, including anaphylactic/anaphylactoid reactions and bronchospasm. Musculoskeletal and connective tissue disorders: arthritis, myalgia Nervous system disorders: Acute disseminated encephalomyelitis, Guillain-Barré syndrome, motor neuron disease, paralysis, seizures, transverse myelitis.  And indeed CHD is in contact with many people, mostly children, with exactly these conditions resulting from this Merck vaccine.

There are currently 80 lawsuits before the courts against Merck for damages claimed to have been caused by their HPV vaccine. Hundreds more are now being prepared, with the potential for a massive class action case to develop. These lawsuits have won standing in US District Courts and have bypassed The National Vaccine Injury Compensation Program no-fault compensation program (Vaccine Court) because the allegations of fraud within Merck’s vaccine trials have been accepted by judges. This important story is one your paper should be invested in telling, not drug marketing and lobbying dressed as social opinion. The largest demographic of injured plaintiffs appears to be girls engaged in strenuous athletics.

Dr. Bresnitz makes false claims that the “HPV vaccine is, in short, a lifesaver.  By preventing several types of cancer, it can save thousands of US lives each year”.  Considering the tragic outcomes thousands of children and adults have experienced from HPV shots, this claim is dangerous and reckless. There are no valid studies showing the vaccine for HPV prevents cervical cancer. However, there are studies suggesting the vaccine could increase the risk of cancer.
The piece actually confirms this connection for the critical thinkers in your audience. Since this vaccine has hit the market and reached over 50% uptake, cervical cancer rates have correspondingly risen in every country where it is being liberally administered.

Detection and treatment of cervical cancer has advanced so significantly over the past 30 years that those at highest risk, between 30 and 45 years of age, who routinely see a physician and take a PAP test are at extremely low risk of death from this cancer.  But since the introduction of the HPV vaccine in children cervical cancers are now being more commonly discovered in women in their 20s and younger.

The National Cancer Institute’s Surveillance, Epidemiology, and End Results Program (SEER) data and another U.S. study found the HPV vaccine has no effect on reducing cancer rates. Two other registry-based studies in Australia and the U.K. suggest that HPV vaccination is associated with increased cervical cancer rates in certain age groups.

If the Inquirer were not in the business of marketing drugs and vaccines, your editorial board would be certain to seize on this important and scandalous public health story. Perhaps Dr. Bresnitz has relinquished his Merck conflict of interest, but the bigger disclosure the Inquirer must make to their readership is what drug industry conflicts of interest this paper holds.

Pennsylvania Chapter of Children’s Health Defense